- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02427347
Acupuncture in the Regulation of Dai Meridian for the Metabolism of Visceral Adipose Tissue in Abdominal Obese Patients
August 16, 2018 updated by: Hui Hu, Dongfang Hospital Beijing University of Chinese Medicine
A Randomized Controlled Clinical Trial of Acupuncture on Regulating Dai Meridian for Visceral Fat Metabolism in Abdominal Obesity.
To evaluate the effectiveness of acupuncture therapy combined with healthy education for patients with abdominal obesity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This subject is a prospective, single-blind, parallel-group, randomized controlled clinical trial.120
patients with abdominal obesity are allocated into two groups with a ratio of 2:1.Randomized series was generated by computer.
The allocation was concealed.
Patients in the intervention group are received acupuncture therapy and healthy education.
Patients in the control group are only given healthy education.
The treatment in both intervention group and control group lasts for 8 weeks.
Comparison of two groups of patients with abdominal fat thickness, fasting serum visfatin concentration, simple anthropometric parameters (including body weight, body mass index, waist circumference, hip circumference, waist-to-hip radio, waist-to-height radio, the percentage of body fat), fasting blood glucose, fasting insulin, glycosylated hemoglobin, fasting blood lipid (total cholesterol, triglyceride, high density lipoprotein, low density lipoprotein), uric acid, blood pressure, insulin resistance level, and obesity related lifestyle survey.
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100078
- Department of Acupuncture and Moxibustion, Dongfang Hospital, Beijing University of Chinese Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Met the diagnostic criteria of abdominal obesity (waist circumference of male ≥ 90cm, waist circumference of female ≥ 80cm);
- Ultrasound viscerofatty index ≥ 3;
- Age between 18-70 years old;
- Signed informed consent voluntarily.
Exclusion Criteria:
- Secondary obesity caused by endocrine, hereditary, nervous system,or drugs;
- Within 3 months adjusted drug therapy for diabetes or hypertension or hyperlipidemia;
- undergoing other therapies for reducing body mass and waist circumference, such as surgery, medication, etc;
- participating or have participated in other studies;
- pregnant or breast-feeding women;
- critically ill, having hepatic-renal dysfunction or mental illness;
- severe impairment in sight and hearing.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Intervention including acupuncture treatment and healthy education.
|
Acupuncture needles of 0.3mm in diameter and 100mm in length are inserted into gallbladder-meridian(GB)26 about 25-65mm deep by an angle of 15°, following the path of Dai Meridian (towards medial and downside) .
The other acupoints are inserted with needles of 0.25-0.3mm in diameter and 25-40mm in length approximately 10-30mm deep, with an angle of 90°.
Electro-acupuncture is applied to both sides of GB26 and stomach-meridian(ST)25: cathode is connected to GB26; anode to ST25.
Dense-disperse wave pattern and a wave frequency of 2/100 Hertz is chosen.
The intensity of the electro-acupuncture is adjusted on average 4-8 milliampere.
The needles are subsequently retained for 20min.
The results of the study are based on 8 weeks, each week consisting of 3 sessions.
Healthy knowledge lectures and issuing brochures are given.
Education of patients for conditioning and changing bad habits, diet, quit smoking, limit alcohol consumption, salt restriction, appropriate increase in physical activity.
|
|
Other: Control group
Healthy education is given as a baseline treatment.
|
Healthy knowledge lectures and issuing brochures are given.
Education of patients for conditioning and changing bad habits, diet, quit smoking, limit alcohol consumption, salt restriction, appropriate increase in physical activity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes from Baseline in abdominal subcutaneous fat thickness at 8 weeks
Time Frame: baseline and 8 weeks
|
Including subcutaneous fat thickness 1 and 2
|
baseline and 8 weeks
|
|
Changes from Baseline in abdominal visceral fat thickness at 8 weeks
Time Frame: baseline and 8 weeks
|
Including visceral fat thickness 1 and 2
|
baseline and 8 weeks
|
|
Change from Baseline in antero-hepatic fat thickness at 8 weeks
Time Frame: baseline and 8 weeks
|
Antero-hepatic fat thickness (AHF) was determined by the distance of peritoneum to the hepatic cortex at the subcostal level.
|
baseline and 8 weeks
|
|
Change from Baseline in perirenal fat thickness at 8 weeks
Time Frame: baseline and 8 weeks
|
Perirenal fat thickness (PRF) was determined by the thickest one of the perirenal fat capsule of the right kidney short axis, when the right renal short axis and the maximum width of the renal sinus were clearly displayed.
|
baseline and 8 weeks
|
|
Change from Baseline in ultrasound viscerofatty index at 8 weeks
Time Frame: baseline and 8 weeks
|
ultrasound viscerofatty index (UVI) = (visceral fat thickness 1 + visceral fat thickness2)/(subcutaneous fat thickness 1 + subcutaneous fat thickness 2)
|
baseline and 8 weeks
|
|
Change from Baseline in fasting serum visfatin at 8 weeks
Time Frame: baseline and 8 weeks
|
5ml venous blood was told after an 8 hours fast.
Visfatin was measured by enzyme-linkedimmuno sorbent assay (ELISA).
|
baseline and 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in body weight
Time Frame: baseline, 4 weeks and 8 weeks
|
It's made at the situation of fasting, after emptying bowels, with minimal clothing, without headdress and footwear, at the end of expiration.
|
baseline, 4 weeks and 8 weeks
|
|
Change from Baseline in body mass index
Time Frame: baseline, 4 weeks and 8 weeks
|
Body mass index (BMI) = body weight(kg)/height(m)/height(m)
|
baseline, 4 weeks and 8 weeks
|
|
Change from Baseline in waist circumference
Time Frame: baseline, 4 weeks and 8 weeks
|
WC was measured at the level between the inferior portion of 12th rib and iliac crest.
|
baseline, 4 weeks and 8 weeks
|
|
Change from Baseline in hip circumference
Time Frame: baseline, 4 weeks and 8 weeks
|
HC was measured at the level of the most prominent point of the pelvis.
|
baseline, 4 weeks and 8 weeks
|
|
Change from Baseline in waist-to-hip radio
Time Frame: baseline, 4 weeks and 8 weeks
|
waist-to-hip radio (WHR) = waist circumference(cm)/hip circumference(cm)
|
baseline, 4 weeks and 8 weeks
|
|
Change from Baseline in waist-to-height radio
Time Frame: baseline, 4 weeks and 8 weeks
|
waist-to-height radio (WHtR) = waist circumference(cm)/height(cm)
|
baseline, 4 weeks and 8 weeks
|
|
Change from Baseline in the percentage of body fat
Time Frame: baseline, 4 weeks and 8 weeks
|
the percentage of body fat = 1.2×BMI+0.23×age-5.4-10.8×gender(M=1,F=0)
|
baseline, 4 weeks and 8 weeks
|
|
Change from Baseline in fasting blood glucose at 8 weeks
Time Frame: baseline and 8 weeks
|
5ml venous blood was collected after an 8 hours fast.
It was tested by our hospital's laboratory.
|
baseline and 8 weeks
|
|
Change from Baseline in fasting insulin at 8 weeks
Time Frame: baseline and 8 weeks
|
5ml venous blood was collected after an 8 hours fast.
It was tested by our hospital's laboratory.
|
baseline and 8 weeks
|
|
Change from Baseline in glycosylated hemoglobin at 8 weeks
Time Frame: baseline and 8 weeks
|
5ml venous blood was collected after an 8 hours fast.
It was tested by our hospital's laboratory.
|
baseline and 8 weeks
|
|
Change from Baseline in fasting total cholesterol at 8 weeks
Time Frame: baseline and 8 weeks
|
5ml venous blood was collected after an 8 hours fast.
It was tested by our hospital's laboratory.
|
baseline and 8 weeks
|
|
Change from Baseline in fasting triglyceride at 8 weeks
Time Frame: baseline and 8 weeks
|
5ml venous blood was collected after an 8 hours fast.
It was tested by our hospital's laboratory.
|
baseline and 8 weeks
|
|
Change from Baseline in fasting high density lipoprotein cholesterol at 8 weeks
Time Frame: baseline and 8 weeks
|
5ml venous blood was collected after an 8 hours fast.
It was tested by our hospital's laboratory.
|
baseline and 8 weeks
|
|
Change from Baseline in fasting low density lipoprotein cholesterol at 8 weeks
Time Frame: baseline and 8 weeks
|
5ml venous blood was collected after an 8 hours fast.
It was tested by our hospital's laboratory.
|
baseline and 8 weeks
|
|
Change from Baseline in fasting uric acid at 8 weeks
Time Frame: baseline and 8 weeks
|
5ml venous blood was collected after an 8 hours fast.
It was tested by our hospital's laboratory.
|
baseline and 8 weeks
|
|
Change from Baseline in blood pressure at 8 weeks
Time Frame: baseline and 8 weeks
|
baseline and 8 weeks
|
|
|
Change from Baseline in insulin resistance level at 8 weeks
Time Frame: baseline and 8 weeks
|
baseline and 8 weeks
|
|
|
Change from Baseline in obesity related lifestyle survey at 8 weeks
Time Frame: baseline and 8 weeks
|
baseline and 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Chair: Hui Hu, doctor, Department of Acupuncture and Moxibustion, Dongfang Hospital, Beijing University of Chinese Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2014
Primary Completion (Actual)
April 1, 2015
Study Completion (Actual)
September 1, 2017
Study Registration Dates
First Submitted
April 13, 2015
First Submitted That Met QC Criteria
April 27, 2015
First Posted (Estimate)
April 28, 2015
Study Record Updates
Last Update Posted (Actual)
August 17, 2018
Last Update Submitted That Met QC Criteria
August 16, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Z141107002514079
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Sun Yat-sen UniversityNot yet recruitingMetabolic Syndrome Risk Factors | Metabolic Syndrome (MetS)China
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityRecruiting
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityEnrolling by invitationMetabolic Syndrome (MetS)China
-
National University Health System, SingaporeRecruitingMetabolic Syndrome | Metabolic Syndrome (MetS)Singapore
-
University of KhartoumMinistry of Higher Education and Scientific Research, Republic of SudanCompletedMetabolic Syndrome in Postmenopausal FemalesSudan
-
Hacettepe UniversityCompletedMetabolic Syndrome | Metabolic Syndrome Obesity | Metabolic Syndrome ParametersTurkey
-
Universidad de los Andes, ChileCompleted
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
-
University of Missouri-ColumbiaRecruitingGlucose Metabolism Disorders | Metabolic Syndrome | Metabolic Syndrome, Protection AgainstUnited States
-
Mayo ClinicCompleted
Clinical Trials on Acupuncture
-
University of ZurichCharite University, Berlin, Germany; First Teaching Hospital of Tianjin University...CompletedExperimental Dental PainSwitzerland
-
Federal University of São PauloCompleted
-
University of SkövdeCompleted
-
National Research Centre of Complementary and Alternative...Norwegian Acupuncture CollegeUnknown
-
Chengdu University of Traditional Chinese MedicineChongqing Medical University; Hunan University of Traditional Chinese MedicineCompletedFunctional Dyspepsia | Postprandial Distress SyndromeChina
-
University of MichiganMassachusetts General Hospital; National Center for Complementary and Integrative...Completed
-
University Medicine GreifswaldRecruitingGagging During Transesophageal EchocardiographyGermany
-
Egyptian Chinese UniversityCompleted
-
Chang Gung Memorial HospitalRecruitingIntracranial HemorrhagesTaiwan
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruiting